Optimal Synergy Between Leading-edge Computational Science and Therapeutics Development
The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approaches, are extensively enlighten drug discovery and development landscape for the effective treatment of diseases. AI is pursued to provide the best suited approach to leverage scientific literature, patient’s omics-data and overall clinical data, to drive smart decisions.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AcuraStem
- BenevolentAI
- Berg
- Evid Science
- FDNA
- Inoplexus
- Kyndi
- ReviveMed
- Standigm
- Structura Bio